JEFFREY GRETZ: Open Payments
NPI 1558342691 · MC MURRAY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,411 in 194 payments from 26 companies in 2025. Trend: 2023 $2,482 · 2024 $2,439 · 2025 $3,411
Food & beverage: $3,411
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $666 |
| Novo Nordisk Inc | 26 | $468 |
| PFIZER INC. | 18 | $250 |
| Currax Pharmaceuticals LLC | 24 | $241 |
| Janssen Pharmaceuticals, Inc | 5 | $198 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $187 |
| AstraZeneca Pharmaceuticals LP | 7 | $166 |
| Amgen Inc. | 10 | $157 |
| Lilly USA, LLC | 9 | $144 |
| Abbott Laboratories | 6 | $130 |
Products named: QULIPTA, SPRAVATO, ONZETRA XSAIL, JARDIANCE, ELIQUIS, MOUNJARO, FREESTYLE LIBRE 3, Rybelsus.
Industry payments across PA — which companies pay providers there.
